Public drug program spending for seniors in Canada by top drug classes 2022
This statistic displays the top 10 drug classes based on total public drug program expenditures for seniors in Canada in 2022. In that year, drug program spending for seniors dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol totaled to some 279 million Canadian dollars.